|

Empagliflozin (EMPA) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • Pancreatitis, Acute1
  • Pancreatitis, Chronic1
  • Diabetes Mellitus1
  • Diabetes1

Rochester, Minnesota1 trial

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus

Mayo Clinic

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.